Home Technology Bioventix And 2 British Biotech Stocks To Watch
Technology

Bioventix And 2 British Biotech Stocks To Watch

Share


AI is pulling huge amounts of capital into data centres and specialised computing, and that surge in demand is rippling into healthcare research that depends on complex modelling. British biotechnology stocks sit right in the crosshairs of that shift, with lab science and computing power increasingly tied together. This article highlights three UK listed biotech stocks from our quality focused screener that could deserve a closer look now.

The three British biotechnology stocks below are only a sample from a wider pool, and the full screen surfaced 4 more companies with equally compelling stories that are not covered here. To identify and analyze those extra biotech opportunities with similar balance sheet strength and value traits, head straight into the Biotech Stocks screener.

Overview: Bioventix develops and supplies sheep monoclonal antibodies and test kits used in diagnostic assays for thyroid, vitamin D, cardiac and oncology testing.

Operations: The group generated about £13 million from biotechnology activities, with roughly £11 million coming from customers outside the UK and European Union.

Market Cap: £102 million

Bioventix plugs directly into the Biotech Stocks screener theme through its diagnostic antibodies, pairing biotech risk with established profitability. Earnings sit on a 58.7% net margin and a 66.7% ROE, while the P/E of 13.4x undercuts both peer and sector averages. That combination of strong economics and low headline valuation only holds together if one unseen pressure stays contained.

If you want to see whether that pressure point is already priced in, go straight to the 2 key rewards and 1 important major warning sign for the full picture hiding behind Bioventix’s margins.

AIM:BVXP P/E Ratio as at Nov 2026
AIM:BVXP P/E Ratio as at Nov 2026

Overview: Oxford Biomedica provides viral vector development and manufacturing for gene and cell therapies, anchored by its LentiVector and AAV platform technologies.

Operations: Oxford Biomedica generates most of its £175 million revenue from manufacturing services at £88 million and development work at £60 million, primarily from United States clients.

Market Cap: £588 million

Oxford Biomedica brings the biotech screener theme to life because its viral vector platforms sit directly behind high risk, high payoff gene therapies. The bearish analyst Narrative on Simply Wall St focuses squarely on how that opportunity interacts with the cost of running a multi site manufacturing network.

“While contracted orders and revenue backlog have risen into the mid hundreds of millions of pounds, the earlier operating EBITDA loss of £7.8 million and the impairment at the France site indicate that if program timing issues reappear when late stage projects transition to commercial supply, the fixed cost base could keep EBITDA margins below current expectations.”

The real swing factor for Oxford Biomedica is what happens if one assumption about how quickly those late stage contracts ramp fails.

If that contract ramp proves slower or faster than expected, reading the full narrative for Oxford Biomedica shows how Oxford Biomedica’s cash profile could rapidly decouple from today’s assumptions.

LSE:OXB Revenue & Expenses Breakdown as at Nov 2026
LSE:OXB Revenue & Expenses Breakdown as at Nov 2026

Overview: Diaceutics runs the DXRX data and analytics platform that helps pharma and biotech companies commercialize precision medicine diagnostics and biomarker testing.

Operations: Diaceutics generates £41 million from medical labs and research services, with about £39 million coming from North American clients.

Market Cap: £156 million

Diaceutics ties cleanly into the Biotech Stocks screener because DXRX helps drug developers find the right patients for targeted therapies, using real world diagnostic data rather than hope. Revenue is growing, the business remains loss making, and the potential reward from that precision medicine rollout depends on how one early profitability assumption holds up.

That early profitability hinge is exactly what the analyst forecasts for Diaceutics unpack so you can see where Diaceutics could accelerate or stall next.

AIM:DXRX Earnings & Revenue Growth as at Nov 2026
AIM:DXRX Earnings & Revenue Growth as at Nov 2026

Seeking Alternatives Before The Crowd?

Fresh biotech ideas can move quickly. Breakout setups, momentum shifts and quietly developing stories that are under the radar for now all risk getting crowded once attention spikes, so consider your options early.

This article is general in nature and was produced with the assistance of AI automation, based on data and analysis from Simply Wall St. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Technology

UK Launches Secret Operation to Protect Supermarket Fridges From Hackers

Supermarket fridges are not usually something people associate with national cybersecurity. However,...

Technology

UK operation wards off risk of cyber-attack on supermarket fridges and freezers | Cybercrime

A secret government cybersecurity operation recently warded off the risk of a...

Technology

Fridge hacks: UK firms race to secure refrigeration systems

Tens of thousands of fridges and freezers at UK supermarkets, warehouses, restaurants,...

Technology

Secret operation protects thousands of freezers from being hacked across the UK | News UK

Earlier this month, thousands of refrigerators in Europe were targeted (Picture: Getty)...